IMMUNITYBIO ANNOUNCES FDA SUBMISSIONS OF SUPPLEMENTAL BLA FOR NMIBC PAPILLARY DISEASE AND FOR EXPANDED ACCESS OF ANKTIVA® TO TREAT LYMPHOPENIA

Reuters · 4d ago

Please log in to view news